A single-center, randomized, open-label, 12 months study, with two parallel group to compare the efficacy of everolimus combination + tacrolimus in regression of left ventricular hypertrophy vs tacrolimus + mycophenolate mofetil in renal transplant patients in the maintenance phase.
Phase of Trial: Phase IV
Latest Information Update: 06 Oct 2016
At a glance
- Drugs Everolimus (Primary) ; Mycophenolate mofetil; Tacrolimus
- Indications Left ventricular hypertrophy
- Focus Therapeutic Use
- 06 Oct 2016 New trial record